Showing 1 - 8 results of 8 for search 'Sabina A Murphy', query time: 0.03s Refine Results
  1. 1
    Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

    Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome by Simon Correa, David A. Morrow, Eugene Braunwald, Richard Y. Davies, Erica L. Goodrich, Sabina A. Murphy, Christopher P. Cannon, Michelle L. O'Donoghue

    Published 2018-10-01
    Get full text
    Article
  2. 2
    Multimarker Risk Stratification in Patients With Acute Myocardial Infarction

    Multimarker Risk Stratification in Patients With Acute Myocardial Infarction by Michelle L. O'Donoghue, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Nihar R. Desai, Matthew W. Sherwood, Sabina A. Murphy, Robert E. Gerszten, Marc S. Sabatine

    Published 2016-05-01
    Get full text
    Article
  3. 3
    Privacy-aware multi-institutional time-to-event studies

    Privacy-aware multi-institutional time-to-event studies by Julian Späth, Julian Matschinske, Frederick K. Kamanu, Sabina A. Murphy, Olga Zolotareva, Mohammad Bakhtiari, Elliott M. Antman, Joseph Loscalzo, Alissa Brauneck, Louisa Schmalhorst, Gabriele Buchholtz, Jan Baumbach

    Published 2022-09-01
    Get full text
    Article
  4. 4
    Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

    Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) by Eri Toda Kato, Christopher P. Cannon, Michael A. Blazing, Erin Bohula, Sema Guneri, Jennifer A. White, Sabina A. Murphy, Jeong‐Gun Park, Eugene Braunwald, Robert P. Giugliano

    Published 2017-11-01
    Get full text
    Article
  5. 5
    Privacy-aware multi-institutional time-to-event studies.

    Privacy-aware multi-institutional time-to-event studies. by Julian Späth, Julian Matschinske, Frederick K Kamanu, Sabina A Murphy, Olga Zolotareva, Mohammad Bakhtiari, Elliott M Antman, Joseph Loscalzo, Alissa Brauneck, Louisa Schmalhorst, Gabriele Buchholtz, Jan Baumbach

    Published 2022-09-01
    Get full text
    Article
  6. 6
    Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)‐TIMI 50

    Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Preventi... by Stephen K. Kidd, Marc P. Bonaca, Eugene Braunwald, Gaetano M. De Ferrari, Basil S. Lewis, Piera A. Merlini, Sabina A. Murphy, Benjamin M. Scirica, Harvey D. White, David A. Morrow

    Published 2016-07-01
    Get full text
    Article
  7. 7
    Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

    Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial by Christina L. Fanola, Christian T. Ruff, Sabina A. Murphy, James Jin, Anil Duggal, Noe A. Babilonia, Piyamitr Sritara, Michele F. Mercuri, Pieter W. Kamphuisen, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano

    Published 2018-08-01
    Get full text
    Article
  8. 8
    Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

    Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial by Eri Toda Kato, Robert P. Giugliano, Christian T. Ruff, Yukihiro Koretsune, Takeshi Yamashita, Robert Gabor Kiss, Francesco Nordio, Sabina A. Murphy, Tetsuya Kimura, James Jin, Hans Lanz, Michele Mercuri, Eugene Braunwald, Elliott M. Antman

    Published 2016-05-01
    Get full text
    Article

Search Tools: